Mirus Capital Advisors Expands Life Sciences & Healthcare Investment Banking Team with Strategic Additions of Thomas Busby and Nick Frame, PhD
Mirus Capital Advisors, a leading independent middle-market investment banking firm, is pleased to announce the addition of seasoned industry experts, Thomas (Thom) Busby and Nick Frame, PhD, to its growing life sciences and healthcare coverage team. With a combined 25+ years’ experience in mergers and acquisitions and capital raising, Busby and Frame have advised and led dozens of senior management teams through complex financial transactions and strategic processes. Their addition reflects the firm’s long-term and growing commitment to the healthcare sector, and the entrepreneurs and investors who fuel the industry’s growth.
Busby and Frame bring a proven track record of guiding founders, innovators, executives, and investors through a full spectrum of high-impact transactions, including mergers & acquisitions (M&A), private equity/debt capital raises, divestments, majority/minority recapitalizations, strategic build-to-buy investments, and corporate partnerships. Busby and Frame possess deep industry and technical knowledge in the biopharmaceutical, medical device, diagnostics, instrumentation and related life sciences services verticals (pharma/device services, CDMOs, CROs, laboratories, consultancies) in addition to clinically-oriented HCIT and consumer health technologies.
“Mirus has a longstanding focus on the healthcare industry, and we are excited to have Thom and Nick join our team,” commented Alan Fullerton, Partner, at Mirus.
Together, Busby and Frame will focus on assisting life sciences and healthcare senior management teams in executing strategic growth opportunities, navigating complex financial transactions, and realizing maximum and sustained value for their businesses. The duo recently advised on a strategic merger between ZIEN Medical Technologies, a medical device contract design and manufacturing organization, and Averra Holdings, LLC, a provider of specialized packaging solutions with a focus on the medical device industry and a portfolio company of Banner Capital.
“With a nearly forty-year history of providing world-class advisory services to the middle market, Mirus stands apart from the competition in its truly expert-led, client-focused approach and independent partnership,” said Busby, who is joining the firm as Partner. “The firm’s commitment to transactional and process excellence, combined with its sophistication and dealmaking history and passion for client success, made Mirus a natural choice.”
“Capital markets and the healthcare industry are at an inflection point,” said Frame, who is joining the firm as Director. “Amidst these recent developments, middle market management teams and Boards require a knowledgeable and experienced advisor, equally well versed in the underlying product or service offering as they are the market and transaction process. Thom and I are excited to assist these companies in hitting their next strategic and financial milestones.”
Mirus has long been recognized for its strength in advising middle-market companies across technology, industrial, business services, and consumer sectors. The expansion of its Life Sciences and Healthcare practice underscores the firm’s dedication to industries that are driving innovation and improving the lives of others.
About Mirus Capital Advisors
Successful business owners have turned to Mirus Capital Advisors for more than 35 years to help them realize their ultimate accomplishment – the sale of their business. As a mid-market investment bank focused on mergers and acquisitions, Mirus drives successful deals for companies in the technology, industrial, business services, consumer, and healthcare sectors. Mirus has proven time and again that its deep industry expertise, focus on relationships, thorough preparation, and unwavering commitment to every deal lead to meaningful accomplishments for business owners. For more, visit www.merger.com.